Filed before 2025Filed 10 October 2023
Avalyn Pharma Inc. raised $189M
Avalyn Pharma Inc., a biotech company based in Seattle, WA, raised $189M in a new equity round, according to a filing dated 10 October 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 10 October 2023
- Round
- Equity round
- Amount sold
- $189M
- Offering size
- $189M
- Investors so far
- 26
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 99% of the 1,396 tracked raises with an amount filed in 2023, and than 99% of the 142 in biotech.
Avalyn Pharma Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 10 Oct 2023 | New filing | $189M | This raise |
| 8 May 2020 | New filing | $35.5M | Another raise |
| 24 May 2017 | Amended filing | $18.2M | Another raise |
| 24 Mar 2017 | New filing | $16.6M | Another raise |
More with 3x5 RiverVest on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.